176 related articles for article (PubMed ID: 31481756)
1. Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons.
Halikere A; Popova D; Scarnati MS; Hamod A; Swerdel MR; Moore JC; Tischfield JA; Hart RP; Pang ZP
Mol Psychiatry; 2020 Jul; 25(7):1406-1419. PubMed ID: 31481756
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol.
Scarnati MS; Boreland AJ; Joel M; Hart RP; Pang ZP
Alcohol; 2020 Sep; 87():97-109. PubMed ID: 32561311
[TBL] [Abstract][Full Text] [Related]
3. Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry.
Popova D; Desai N; Blendy JA; Pang ZP
J Neurosci; 2019 Jul; 39(29):5685-5696. PubMed ID: 31109961
[TBL] [Abstract][Full Text] [Related]
4. Implication of OPRM1 A118G Polymorphism in Opioids Addicts in Pakistan: In vitro and In silico Analysis.
Ahmed M; Ul Haq I; Faisal M; Waseem D; Taqi MM
J Mol Neurosci; 2018 Aug; 65(4):472-479. PubMed ID: 30033503
[TBL] [Abstract][Full Text] [Related]
5. A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain.
Oertel BG; Kettner M; Scholich K; Renné C; Roskam B; Geisslinger G; Schmidt PH; Lötsch J
J Biol Chem; 2009 Mar; 284(10):6530-5. PubMed ID: 19116204
[TBL] [Abstract][Full Text] [Related]
6. A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin.
Kapur S; Sharad S; Singh RA; Gupta AK
J Integr Neurosci; 2007 Dec; 6(4):511-22. PubMed ID: 18181266
[TBL] [Abstract][Full Text] [Related]
7. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.
Beyer A; Koch T; Schröder H; Schulz S; Höllt V
J Neurochem; 2004 May; 89(3):553-60. PubMed ID: 15086512
[TBL] [Abstract][Full Text] [Related]
8. A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.
Huang P; Chen C; Mague SD; Blendy JA; Liu-Chen LY
Biochem J; 2012 Jan; 441(1):379-86. PubMed ID: 21864297
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2014 Sep; 171(18):4273-88. PubMed ID: 24846673
[TBL] [Abstract][Full Text] [Related]
10. Genetic-epigenetic interaction modulates μ-opioid receptor regulation.
Oertel BG; Doehring A; Roskam B; Kettner M; Hackmann N; Ferreirós N; Schmidt PH; Lötsch J
Hum Mol Genet; 2012 Nov; 21(21):4751-60. PubMed ID: 22875838
[TBL] [Abstract][Full Text] [Related]
11. Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1).
Knapman A; Connor M
Br J Pharmacol; 2015 Jan; 172(2):349-63. PubMed ID: 24527749
[TBL] [Abstract][Full Text] [Related]
12. Mouse model of OPRM1 (A118G) polymorphism has altered hippocampal function.
Mague SD; Port RG; McMullen ME; Carlson GC; Turner JR
Neuropharmacology; 2015 Oct; 97():426-35. PubMed ID: 25986698
[TBL] [Abstract][Full Text] [Related]
13. Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment.
Tolami HF; Sharafshah A; Tolami LF; Keshavarz P
J Mol Neurosci; 2020 Apr; 70(4):504-513. PubMed ID: 31853823
[TBL] [Abstract][Full Text] [Related]
14. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.
Zhang Y; Wang D; Johnson AD; Papp AC; Sadée W
J Biol Chem; 2005 Sep; 280(38):32618-24. PubMed ID: 16046395
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
Browne CA; Erickson RL; Blendy JA; Lucki I
Neuropharmacology; 2017 May; 117():401-407. PubMed ID: 28188737
[TBL] [Abstract][Full Text] [Related]
16. Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence.
Smith RJ; Doyle GA; Han AM; Crowley JJ; Oslin DW; Patkar AA; Mannelli P; Demaria PA; O'brien CP; Berrettini WH
Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):105-9. PubMed ID: 15558714
[TBL] [Abstract][Full Text] [Related]
17. A118G Mu Opioid Receptor polymorphism increases inhibitory effects on CaV2.2 channels.
Lopez Soto EJ; Raingo J
Neurosci Lett; 2012 Aug; 523(2):190-4. PubMed ID: 22796651
[TBL] [Abstract][Full Text] [Related]
18. Oprm1 A112G, a single nucleotide polymorphism, alters expression of stress-responsive genes in multiple brain regions in male and female mice.
Collins D; Randesi M; da Rosa JC; Zhang Y; Kreek MJ
Psychopharmacology (Berl); 2018 Sep; 235(9):2703-2711. PubMed ID: 30027498
[TBL] [Abstract][Full Text] [Related]
19. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians.
Daher M; Costa FM; Neves FA
Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975
[TBL] [Abstract][Full Text] [Related]
20. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.
Ray R; Ruparel K; Newberg A; Wileyto EP; Loughead JW; Divgi C; Blendy JA; Logan J; Zubieta JK; Lerman C
Proc Natl Acad Sci U S A; 2011 May; 108(22):9268-73. PubMed ID: 21576462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
